Komori
Hi-CRATES (4172) · InitiativeAdvanced

Use of Funds Raised for Product Development Investment and Internal Digitalization

First written in FY2021-Q1. 6 of 10 entries say "Advanced", first in FY2021. Latest entry: FY2025.

10entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2021-Q1AdvancedFY2021 – FY2022AdvancedFY2023-Q2 – FY2023-Q3RestatedFY2024-Q1 – FY2024-Q2AdvancedFY2024 – FY20252021: 220212022: 120222023: 320232024: 320242025: 12025
Same theme, other companies

The whole theme swung hardest in 2023: 1 of 7 companies on the "Worse" side.

9 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 18 companies compared. The sentences above are computed from all 18.
Full recordFilings, disclosures and news, newest first
  1. FY2025AdvancedAnnual report

    「Total research and development expenses for the fiscal year were ¥88.880 million.」

    Research and development expenses increased from ¥52.945 million in the previous fiscal year to ¥88.880 million. Development is under way for Revo.11, Perio Judge, Perio Judge II, generative AI, cloud services, facial recognition, remote support and other products.
  2. FY2024AdvancedAnnual report

    「Total research and development expenses for the fiscal year were ¥52.945 million.」

    The company continued research and development in areas including AI-enabled voice electronic medical records, periodontal disease testing, supplementary medical records, cloud-based reservations, facial recognition and remote support, and recorded research and development expenses of ¥52.945 million.
  3. FY2024-Q2RestatedAnnual report

    「Total research and development expenses for the second quarter cumulative period were ¥25.772 million. There were no material changes in the status of the company's research and development activities during the second quarter cumulative period.」

    The company reported research and development expenses of ¥25.772 million for the second quarter cumulative period and stated that there were no material changes in the status of its research and development activities.
  4. FY2024-Q1RestatedAnnual report

    「Total research and development expenses for the first quarter cumulative period were ¥25.772 million. There were no material changes in the status of the company's research and development activities during the first quarter cumulative period.」

    The company recorded research and development expenses of ¥25.772 million and stated that there were no material changes in the status of its research and development activities related to product development and internal digitalisation.
  5. FY2023-Q3AdvancedAnnual report

    「Property, plant and equipment amounted to ¥1,969.397 million, an increase of ¥184.365 million from the end of the previous fiscal year. The main components were an increase of ¥102.151 million in software, an increase of ¥33.000 million in software under development, and an increase of ¥47.160 million in investment securities associated with the purchase of securities.」

    Investment in software related to product development and internal digitalisation continued, with software increasing by ¥102.151 million and software under development increasing by ¥33.000 million.
  6. FY2023-Q2AdvancedAnnual report

    「Property, plant and equipment amounted to ¥1,970.112 million, an increase of ¥185.080 million from the end of the previous fiscal year. The main components were an increase of ¥113.704 million in software, an increase of ¥33.000 million in software under development, and an increase of ¥25.850 million in investment securities associated with the purchase of securities.」

    Software related to product development and internal digitalisation increased by ¥113.704 million from the end of the previous fiscal year, while software under development increased by ¥33.000 million.
  7. FY2023-Q1RestatedAnnual report

    「Total research and development expenses for the first quarter cumulative period were ¥20.178 million. There were no material changes in the status of the company's research and development activities during the first quarter cumulative period.」

    The company recorded research and development expenses of ¥20.178 million for the first quarter and stated that there were no material changes in the status of its research and development activities.
  8. FY2022AdvancedAnnual report

    「During the fiscal year, the head office division made capital investments of ¥18.171 million in vehicles, ¥6.501 million in tools, fixtures and furniture, and ¥67.417 million in software under development.」

    The company made capital investments related to product development and internal digitalisation, specifying the investment amount for software under development.
  9. FY2021AdvancedAnnual report

    「During the fiscal year, the head office division made capital investments of ¥37.513 million in buildings and structures, ¥12.786 million in tools, fixtures and furniture, and ¥64.105 million in software and software under development.」

    The company invested in software and other assets related to product development and internal digitalisation, and also described a cloud-based new product development plan scheduled for completion in January 2022.
  10. FY2021-Q1First statedAnnual report

    「The funds are scheduled to be allocated as capital expenditure to product development investment and the promotion of internal digitalisation, and as working capital to improving the functionality of existing products and services.」

    The company specifies product development, internal digitalisation and improvements to the functionality of existing products and services as uses of the funds raised through the third-party allotment of shares.
Moved together

"Developing High-Value-Added Products Using AI and the Cloud" moved the same way as this thread, in the same document, in 6 of its 10 moves.

644433★123456
  1. ★This thread
  2. 1Developing High-Value-Added Products Using AI and the Cloud6×
  3. 2Centralized management through an integrated electronic dental records system4×
  4. 3Continuous and Stable Shareholder Returns4×
  5. 4Progress in IT adoption in the dental care industry4×
  6. 5Emphasis on Operating Margin and Customer Count3×
  7. 6Advertising and Trade Show Participation to Raise Awareness3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Hi-CRATES yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Use of Funds Raised for Product Development Investment and Internal Digitalization | Hi-CRATES CO.,LTD. (4172) | Komori